Feature | Atrial Fibrillation | November 07, 2017

New Data and Technology To Treat Atrial Fibrillation

Acutus dipole density EP mapping for ablation procedures.

The FDA recently cleared high-speed Acutus Medical's AcQMap High Resolution image and mapping system and the AcQMap 3-D Imaging and Mapping Catheter.  detects and displays both standard voltage-based and higher resolution dipole density (charge-source) maps. The system combines ultrasound anatomy construction with an ability to map the electrical-conduction of each heartbeat to identify complex arrhythmias across the entire atrial chamber. Following each ablation treatment, the heart can be re-mapped in seconds to continually visualize any changes from the prior mapping.

 

 


November 7, 2017 — Here is an aggregated list of articles detailing the latest clinical data and new device technology news for treating atrial fibrillation (AF or Afib) from the past six months. 

New Technologies to Improve Atrial Fibrillation Ablation

Boston Scientific to Acquire EP Technology Company Apama Medical

VIDEO: Current State of Atrial Fibrillation Ablation Technologies - Interview with Hugh Calkins, M.D.

Intracardiac Echo Should be More Widely Adopted to Minimize Radiation in Catheter Ablations

Mixed Results in PREVAIL Trial Comparing Five-Year Data for LAA Closure Compared to Warfarin

First Smartphone Compatible Insertable Cardiac Monitor Cleared by FDA

Wearable Cardiac Monitors Are Effective for Tracking Atrial Fibrillation Following Ablation

Implantable Cardiac Monitors Detect High Rate of Atrial Fibrillation in Previously Undiagnosed High-Risk Patients

Acutus Medical Receives FDA Clearance for AcQMap Cardiac Mapping Technology

Cryoballoon Ablation Reduces Costs and Resource Utilization

Multi-Electrode RF Balloon Efficient for Acute Pulmonary Vein Isolation

What is New in Electrophysiology Technologies

Smartphone Apps Help Patients and Providers Manage Atrial Fibrillation

CardioFocus Gains European CE Mark for HeartLight Excalibur Laser Ablation Balloon

Medtronic Announces First Enrollments in STOP AF First Clinical Trial

Expert Consensus Released on Catheter, Surgical Ablation of Atrial Fibrillation

Analysis Shows Increased Risk of Early Stroke with New-Onset Atrial Fibrillation Post-TAVR

CASTLE-AF Study Results Indicate Catheter Ablation of Atrial Fibrillation as First-Line Treatment for Heart Failure Patients

Heart Rhythm Society 2017 Late-Breaking Electrophysiology Trials

EMANATE Trial Shows Apixaban Lowers stroke in AF Patients Undergoing Cardioversion

Real-World Analysis Compares Safety, Effectiveness of Apixaban Versus Warfarin

UNC School of Medicine Receives $1.7 Million for Atrial Fibrillation Program Streamlining Patient Care

VIDEO: Demonstration of the AcQMap High-resolution EP Mapping System

Stroke History Higher in Asymptomatic Versus Symptomatic Atrial Fibrillation Patients

Positive European Registry Results For Watchman Left Atrial Appendage Closure Device

Closure of Left Atrial Appendage During Heart Surgery Protects the Brain

Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System

Confirm RX First Implantable Cardiac Monitor to Gain European Approval Using Mobile Phone App Monitoring

Medtronic Reactive ATP Therapy Slows Progression of Atrial Fibrillation in Real-World Population

Newer Anticoagulant Reduces Major Bleeds in AF Ablation

Most Atrial Fibrillation Patients Do Not Get Preventive Drug Before Stroke

 


Related Content

News | Atrial Fibrillation

Feb. 9, 2026 — Argá Medtech has announced positive clinical results from the BURST-AF (NCT05572047) first-in-human trial ...

Home February 09, 2026
Home
News | Atrial Fibrillation

Feb. 9, 2026 — Atraverse Medical presented new clinical and preclinical data at AF Symposium 2026 in Boston, further ...

Home February 09, 2026
Home
News | Atrial Fibrillation

Dec. 19, 2025 — Johnson & Johnson MedTech has announced its sponsorship of a new data collection platform developed by ...

Home December 19, 2025
Home
Feature | Atrial Fibrillation | Jeffrey Olgin, M.D.

Atrial fibrillation (AFib) is one of the most common heart rhythm disorders, but researchers still don’t have a reliable ...

Home September 12, 2025
Home
News | Atrial Fibrillation

Sept. 8, 2025 — Pulse Biosciences, Inc., a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation ...

Home September 08, 2025
Home
News | Atrial Fibrillation

Sept. 8, 2025 — AMO Pharma Ltd., a clinical-stage specialty biopharmaceutical company focusing on rare genetic disorders ...

Home September 08, 2025
Home
Feature | Atrial Fibrillation

Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are at elevated risk for cardiovascular disease.1 ...

Home September 04, 2025
Home
News | Atrial Fibrillation

June 13, 2025 — An international study has shown that targeted online education on atrial fibrillation (AF) for health ...

Home June 16, 2025
Home
News | Atrial Fibrillation

May 21, 2025 — Corify Care recently announced it has entered into a know-how agreement with Mayo Clinic. Corify Care is ...

Home May 22, 2025
Home
News | Atrial Fibrillation

April 25, 2025 – Medtronic plc, a global leader in healthcare technology, recently received U.S. Food and Drug ...

Home April 29, 2025
Home
Subscribe Now